MKA
REGN icon

M. Kulyk & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

M. Kulyk & Associates’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$2.1M Buy
4,005
+1,318
+49% +$692K 0.46% 51
2025
Q1 		$1.7M Buy
2,687
+528
+24% +$335K 0.39% 53
2024
Q4 		$1.54M Buy
+2,159
New +$1.54M 0.33% 52